Share


  

Hi , 


This week, we’re bringing a snapshot of the breakthroughs driving synthetic biology. From AI-powered tools decoding genetic blueprints to nanopore sequencing delivering new insights, innovation is at the forefront. We’re also spotlighting major funding wins for enzyme innovations and AI-driven ingredient discovery, plus a breakthrough in synthetic cells that could redefine medical and tissue engineering. And…don’t miss our Black Friday offer—$250 off 2025 passes—and the chance to join us for a year of discovery and progress!


Huge Black Friday Sale: Get $250 Off ANY SynBioBeta 2025 Pass— Conference, Startup, Student, Non-Profit, or Expo Hall! 


This is a great opportunity to join a vibrant community, explore groundbreaking innovations, and participate in conversations shaping the future of synthetic biology. Don’t miss out—this special offer expires on November 29, and prices will increase at the end of the month. Use code BlackFriday at checkout to secure your spot and connect with the leading minds in synthetic biology today!


 


Human Health Sessions Open for Speaker Recruitment


Did any of these sessions catch your interest? Reach out to us today!


Check Out Our Latest Sponsors and Exhibitors for SynBioBeta 2025!


Tiny Nanopores Spark Big Strides for Synthetic Biology

Nanopore sequencing offers synthetic biologists unparalleled insights into genetic material, driving innovation despite challenges in read quality and user experience compared to other platforms.






Evo: The AI That's Decoding Life's Genetic Blueprint

Trained on 2.7 million microbial genomes, Evo leverages deep learning to predict how small DNA changes affect organism fitness and can generate realistic, functional genomic sequences.


Ferment's $20M Bet: Turning Waste into Wealth with Enzyme Innovation

Ferment raises $20 million to commercialize biology by launching Alchemica, a company that uses proprietary enzymes to increase methane production from waste by 50%.

Invention of Synthetic Life that Talks Back

Basel researchers have coaxed synthetic cells to signal like living cells, in a breakthrough that could reshape medical therapy and tissue engineering.


Shiru Secures $16M to Lead AI-Powered Ingredient Discovery

Shiru’s ProteinDiscovery.ai platform uses AI to identify high-performance ingredients from plants and microbes, reducing R&D costs and time to market.

Like our Digest?

Please feel free to share with friends,

family, and co-workers!


SynBioBeta, LLC

3559 Mount Diablo Boulevard #2, Lafayette, CA 94549

info@synbiobeta.com


Sent to: _t.e.s.t_@example.com

Unsubscribe

SynBioBeta, 3559 Mount Diablo Boulevard #2, Lafayette, CA 94549, United States


Email Marketing by ActiveCampaign